Identification of β2-microglobulin as a urinary biomarker for chronic allograft nephropathy using proteomic methods.
dc.contributor.author | Johnston, Olwyn | |
dc.contributor.author | Cassidy, Hilary | |
dc.contributor.author | O'Connell, Séin | |
dc.contributor.author | O'Riordan, Aisling | |
dc.contributor.author | Gallagher, William | |
dc.contributor.author | Maguire, Patricia B | |
dc.contributor.author | Wynne, Kieran | |
dc.contributor.author | Cagney, Gerard | |
dc.contributor.author | Ryan, Michael P | |
dc.contributor.author | Conlon, Peter J | |
dc.contributor.author | McMorrow, Tara | |
dc.date.accessioned | 2012-06-20T13:43:47Z | |
dc.date.available | 2012-06-20T13:43:47Z | |
dc.date.issued | 2011-08 | |
dc.identifier.citation | Identification of β2-microglobulin as a urinary biomarker for chronic allograft nephropathy using proteomic methods. 2011, 5 (7-8):422-31 Proteomics Clin Appl | en_GB |
dc.identifier.issn | 1862-8354 | |
dc.identifier.pmid | 21751411 | |
dc.identifier.doi | 10.1002/prca.201000160 | |
dc.identifier.uri | http://hdl.handle.net/10147/229912 | |
dc.description.abstract | Chronic allograft nephropathy (CAN) remains the leading cause of renal graft loss after the first year following renal transplantation. This study aimed to identify novel urinary proteomic profiles, which could distinguish and predict CAN in susceptible individuals. | |
dc.language.iso | en | en |
dc.rights | Archived with thanks to Proteomics. Clinical applications | en_GB |
dc.subject.mesh | Adult | |
dc.subject.mesh | Biological Markers | |
dc.subject.mesh | Case-Control Studies | |
dc.subject.mesh | Female | |
dc.subject.mesh | Glomerulonephritis, Membranous | |
dc.subject.mesh | Glomerulosclerosis, Focal Segmental | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Kidney | |
dc.subject.mesh | Kidney Transplantation | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Protein Array Analysis | |
dc.subject.mesh | Proteomics | |
dc.subject.mesh | Software | |
dc.subject.mesh | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | |
dc.subject.mesh | Transplantation, Homologous | |
dc.subject.mesh | beta 2-Microglobulin | |
dc.title | Identification of β2-microglobulin as a urinary biomarker for chronic allograft nephropathy using proteomic methods. | en_GB |
dc.type | Article | en |
dc.contributor.department | School of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Belfield, Dublin, Ireland. | en_GB |
dc.identifier.journal | Proteomics. Clinical applications | en_GB |
dc.description.province | Leinster | en |
html.description.abstract | Chronic allograft nephropathy (CAN) remains the leading cause of renal graft loss after the first year following renal transplantation. This study aimed to identify novel urinary proteomic profiles, which could distinguish and predict CAN in susceptible individuals. |